青霉素G与新型β-内酰胺类抗生素对拟杆菌属临床分离株的活性比较。
Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species.
作者信息
Aldridge K E, Sanders C V, Janney A, Faro S, Marier R L
出版信息
Antimicrob Agents Chemother. 1984 Sep;26(3):410-3. doi: 10.1128/AAC.26.3.410.
Abstract
MICs were determined for 218 clinical isolates of Bacteroides by a broth microdilution method. Imipenem was the most active antibiotic tested. Azlocillin, mezlocillin, and cefoxitin had comparable activities, with resistance among members of the B. fragilis group and B. capillosus. Ceftizoxime was the most active cephalosporin tested. Members of the B. fragilis group showed high levels of resistance to cefotetan and ceftazidime. Resistance to penicillin G varied from 0 to 14%.
摘要
采用肉汤微量稀释法对218株拟杆菌临床分离株进行了最低抑菌浓度（MIC）测定。亚胺培南是所测试的最具活性的抗生素。阿洛西林、美洛西林和头孢西丁具有相当的活性，脆弱拟杆菌群和毛细拟杆菌成员存在耐药情况。头孢唑肟是所测试的最具活性的头孢菌素。脆弱拟杆菌群成员对头孢替坦和头孢他啶表现出高度耐药。对青霉素G的耐药率在0%至14%之间。
相似文献
1
Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species.青霉素G与新型β-内酰胺类抗生素对拟杆菌属临床分离株的活性比较。
Antimicrob Agents Chemother. 1984 Sep;26(3):410-3. doi: 10.1128/AAC.26.3.410.
2
Differences in the in vitro inhibitory and bactericidal activity of ceftizoxime, cefoxitin, cefotetan, and penicillin G against Bacteroides fragilis group isolates. Comparison of time-kill kinetic studies with MIC values.头孢唑肟、头孢西丁、头孢替坦和青霉素G对脆弱拟杆菌属分离株的体外抑菌和杀菌活性差异。时间杀菌动力学研究与最低抑菌浓度值的比较。
Diagn Microbiol Infect Dis. 1990 Jul-Aug;13(4):311-6. doi: 10.1016/0732-8893(90)90023-o.
3
Survey of Bacteroides fragilis group susceptibility patterns in Canada.加拿大脆弱拟杆菌群药敏模式调查。
Antimicrob Agents Chemother. 1992 Feb;36(2):343-7. doi: 10.1128/AAC.36.2.343.
4
Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.新型β-内酰胺类药物对脆弱拟杆菌及其他拟杆菌属临床分离株的活性。
Antimicrob Agents Chemother. 1987 Dec;31(12):2002-4. doi: 10.1128/AAC.31.12.2002.
5
Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns.脆弱拟杆菌群所致菌血症：菌种分布、β-内酰胺酶产生情况及抗菌药物敏感性模式
Antimicrob Agents Chemother. 2003 Jan;47(1):148-53. doi: 10.1128/AAC.47.1.148-153.2003.
6
Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.114株脆弱拟杆菌属菌株对亚胺培南及其他8种抗菌药物的敏感性
Pathology. 1988 Jul;20(3):260-3. doi: 10.3109/00313028809059504.
7
In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin.头孢唑肟对脆弱拟杆菌的体外活性：与苄青霉素、头孢噻吩和头孢西丁的比较。
Antimicrob Agents Chemother. 1981 Sep;20(3):332-5. doi: 10.1128/AAC.20.3.332.
8
The antibiotic sensitivity of the Bacteroides fragilis group in the United Kingdom.英国脆弱拟杆菌群的抗生素敏感性
J Antimicrob Chemother. 1987 Oct;20(4):477-88. doi: 10.1093/jac/20.4.477.
9
Resistance to beta-lactam antibiotics and beta-lactamase production of Bacteroides, Porphyromonas and Prevotella strains.拟杆菌属、卟啉单胞菌属和普雷沃菌属菌株对β-内酰胺类抗生素的耐药性及β-内酰胺酶的产生
Acta Microbiol Immunol Hung. 1995;42(3):287-99.
10
Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.亚胺培南与β-内酰胺类药物联合舒巴坦和克拉维酸在产β-内酰胺酶的脆弱拟杆菌菌株中的活性比较。
J Hyg Epidemiol Microbiol Immunol. 1991;35(2):189-97.
引用本文的文献
1
Synthesis, Pharmacological and Toxicological Screening of Penicillin-Triazole Conjugates (PNTCs).青霉素-三唑共轭物（PNTCs）的合成、药理及毒理学筛选
ACS Omega. 2019 Oct 7;4(17):17230-17235. doi: 10.1021/acsomega.9b01724. eCollection 2019 Oct 22.
2
Use of cephalosporins for prophylaxis and therapy of polymicrobial infection in mice.头孢菌素在小鼠多微生物感染预防和治疗中的应用。
Antimicrob Agents Chemother. 1993 Jul;37(7):1531-5. doi: 10.1128/AAC.37.7.1531.
3
Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢替坦：抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1985 Nov;30(5):382-426. doi: 10.2165/00003495-198530050-00002.
4
Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢唑肟：抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1985 Apr;29(4):281-329. doi: 10.2165/00003495-198529040-00001.
5
Evaluation of three broth disk methods for testing the susceptibility of anaerobic bacteria to imipenem.三种肉汤纸片法检测厌氧菌对亚胺培南敏感性的评估
J Clin Microbiol. 1985 Jun;21(6):875-9. doi: 10.1128/jcm.21.6.875-879.1985.
6
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.亚胺培南/西司他丁。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1987 Mar;33(3):183-241. doi: 10.2165/00003495-198733030-00001.
7
Activity of cefmetazole against anaerobic bacteria.头孢美唑对厌氧菌的活性。
Antimicrob Agents Chemother. 1987 Dec;31(12):2010-2. doi: 10.1128/AAC.31.12.2010.
8
Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria.培养基、pH值和接种量对头孢唑肟和Sch-34343抗厌氧菌活性的影响。
Antimicrob Agents Chemother. 1986 Oct;30(4):626-7. doi: 10.1128/AAC.30.4.626.
9
Recovery of anaerobic bacteria from clinical specimens in 12 years at two military hospitals.两家军队医院12年间临床标本中厌氧菌的分离情况
J Clin Microbiol. 1988 Jun;26(6):1181-8. doi: 10.1128/jcm.26.6.1181-1188.1988.
10
National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteria.美国国家临床实验室标准委员会对厌氧革兰氏阴性菌进行琼脂稀释药敏试验。
Antimicrob Agents Chemother. 1988 Mar;32(3):385-90. doi: 10.1128/AAC.32.3.385.
本文引用的文献
1
Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates.厌氧菌的抗菌药敏性：近期临床分离株
Antimicrob Agents Chemother. 1974 Sep;6(3):311-5. doi: 10.1128/AAC.6.3.311.
2
High-dose cefamandole therapy in obstetric and gynecologic infections.
Am J Obstet Gynecol. 1980 Aug 15;137(8):914-22. doi: 10.1016/s0002-9378(16)32832-0.
3
A survey of Bacteroides susceptibility in the United States.美国拟杆菌药敏情况调查。
J Antimicrob Chemother. 1981 Dec;8 Suppl D:27-31. doi: 10.1093/jac/8.suppl_d.27.
4
Pharmacokinetics of the monobactam SQ 26,776 after single intravenous doses in healthy subjects.
J Antimicrob Chemother. 1981 Dec;8 Suppl E:131-40. doi: 10.1093/jac/8.suppl_e.131.
5
Mechanisms of drug-resistance transfer in Bacteroides fragilis.脆弱拟杆菌中耐药性转移的机制
J Antimicrob Chemother. 1981 Dec;8 Suppl D:59-75. doi: 10.1093/jac/8.suppl_d.59.
6
Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species.革兰氏阴性厌氧杆菌：它们在感染中的作用及对抗菌药物的敏感性模式。I. 鲜为人知的拟杆菌属菌种。
Rev Infect Dis. 1980 Nov-Dec;2(6):914-51. doi: 10.1093/clinids/2.6.914.
7
Factors that affect the in-vitro activity of cephalosporin antibiotics.影响头孢菌素类抗生素体外活性的因素。
J Antimicrob Chemother. 1982 Nov;10 Suppl C:11-23. doi: 10.1093/jac/10.suppl_c.11.
8
The semi-synthetic thienamycin derivative MK0787 and its properties with respect to a range of beta-lactamases from clinically relevant bacterial species.半合成硫霉素衍生物MK0787及其对一系列来自临床相关细菌物种的β-内酰胺酶的特性。
J Antimicrob Chemother. 1981 Mar;7(3):279-85. doi: 10.1093/jac/7.3.279.
9
Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilities.
J Antimicrob Chemother. 1980 Jul;6(4):519-25. doi: 10.1093/jac/6.4.519.
10
N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria.N-甲酰亚胺基硫霉素（MK0787）：对厌氧菌的体外活性
Antimicrob Agents Chemother. 1982 Jan;21(1):168-9. doi: 10.1128/AAC.21.1.168.
Zotero 插件